Ensign Peak Advisors, Inc Akero Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

$58.8 Billion
Q3 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 207,692 shares of AKRO stock, worth $11.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

207,692

Previous 155,044 33.96%

Holding current value

$11.3 Million

Previous $6.28 Million 57.12%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$42.18 - $54.33 $2.22 Million - $2.86 Million	52,648 Added 33.96%	207,692 $9.86 Million
Q3 2024 Nov 14, 2024	SELL	$21.45 - $29.34 $1.77 Million - $2.42 Million	-82,450 Reduced 34.72%	155,044 $4.45 Million
Q2 2024 Aug 13, 2024	BUY	$18.31 - $24.62 $90,634 - $121,869	4,950 Added 2.13%	237,494 $5.57 Million
Q1 2024 May 14, 2024	SELL	$17.76 - $31.18 $12,787 - $22,449	-720 Reduced 0.31%	232,544 $5.87 Million
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $7,397 - $32,714	650 Added 0.28%	233,264 $5.45 Million
Q3 2023 Nov 13, 2023	BUY	$41.19 - $52.25 $2.27 Million - $2.87 Million	55,000 Added 30.97%	232,614 $11.8 Million
Q2 2023 Aug 14, 2023	BUY	$36.89 - $56.88 $75,624 - $116,604	2,050 Added 1.17%	177,614 $8.29 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $50.24 $458,421 - $617,952	12,300 Added 7.53%	175,564 $6.72 Million
Q4 2022 Feb 13, 2023	SELL	$33.44 - $54.8 $226,388 - $370,996	-6,770 Reduced 3.98%	163,264 $8.95 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $1 Million - $3.36 Million	98,543 Added 137.84%	170,034 $5.79 Million
Q2 2022 Aug 12, 2022	BUY	$8.0 - $15.01 $369,648 - $693,552	46,206 Added 182.74%	71,491 $676,000
Q4 2020 Feb 12, 2021	BUY	$25.12 - $29.89 $149,815 - $178,263	5,964 Added 30.87%	25,285 $652,000
Q3 2020 Nov 12, 2020	SELL	$30.79 - $39.92 $242,655 - $314,609	-7,881 Reduced 28.97%	19,321 $595,000
Q2 2020 Aug 12, 2020	BUY	$19.25 - $26.76 $229,710 - $319,327	11,933 Added 78.15%	27,202 $678,000
Q1 2020 May 11, 2020	SELL	$12.8 - $27.05 $109,491 - $231,385	-8,554 Reduced 35.91%	15,269 $324,000
Q4 2019 Feb 14, 2020	BUY	$17.37 - $27.27 $413,805 - $649,653	23,823 New	23,823 $529,000

Others Institutions Holding AKRO

# of Institutions

302

Shares Held

91.5M

Call Options Held

1.05M

Put Options Held

388K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.52B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Akero Therapeutics, Inc. Transaction History